Bookmark Article
Core Laboratories (NYSE:CLB), a provider of reservoir optimization and production enhancement services, reported Q2 2025 earnings on July 23, revealing GAAP revenue of $130.2 million, surpassing expectations of $129.1 million, while adjusted EPS of $0.19 met consensus. Although there were operational improvements in international markets, revenue remained largely unchanged year-over-year.
Want More Context? 🔎






